A pilot study in adults with type 1 diabetes to examine the efficacy of stable non-aqueous liquid glucagon for treatment of severe hypoglycaemia

被引:0
|
作者
Christiansen, M. [1 ]
Cummins, M. [2 ]
Prestrelski, S. [2 ]
Shi, L. [3 ]
Strange, P. [2 ,3 ]
机构
[1] Diablo Clin Res, Walnut Creek, CA USA
[2] Xeris Pharmaceut, Austin, TX USA
[3] Integrated Med Dev, Princeton Jct, NJ USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
737
引用
收藏
页码:S338 / S338
页数:1
相关论文
共 50 条
  • [1] A pilot study of mini-dose glucagon for treatment of non-severe hypoglycaemia in adults with type 1 diabetes
    Haymod, M.
    DuBose, S.
    Rickels, M.
    Wolpert, H.
    Shah, V.
    Sherr, J.
    Weinstock, R.
    Agarwal, S.
    Verdejo, A.
    Cummins, M.
    Newswanger, B.
    Beck, R.
    [J]. DIABETOLOGIA, 2017, 60 : S337 - S337
  • [2] A Pilot Study in Adults with T1DM to Examine the Efficacy of Stable Nonaqueous Glucagon for Treatment of Severe Hypoglycemia
    Strange, Poul
    Cummins, Martin J.
    Prestrelski, Steven J.
    Shi, Leon
    Christiansen, Mark
    [J]. DIABETES, 2017, 66 : LB37 - LB37
  • [3] Glucagon for hypoglycaemia treatment in type 1 diabetes
    Ranjan, Ajenthen G.
    Schmidt, Signe
    Norgaard, Kirsten
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (05)
  • [4] Efficacy, effectiveness and safety of nasal glucagon (NG) as a rescue therapy for severe hypoglycaemia in adults with Type 1 diabetes
    Balogh, E.
    Reviriego, J.
    Jiletcovici, A.
    Thieu, V. T.
    [J]. DIABETIC MEDICINE, 2019, 36 : 130 - 130
  • [5] Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real-world setting
    Seaquist, Elizabeth R.
    Dulude, Helene
    Zhang, Xiaotian M.
    Rabasa-Lhoret, Remi
    Tsoukas, George M.
    Conway, James R.
    Weisnagel, Stanley J.
    Gerety, Gregg
    Woo, Vincent C.
    Zhang, Shuyu
    Carballo, Dolores
    Pradhan, Sheetal
    Piche, Claude A.
    Guzman, Cristina B.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1316 - 1320
  • [6] Efficacy, effectiveness and safety of nasal glucagon as rescue therapy for severe hypoglycaemia in children and adolescents with Type 1 diabetes
    Balogh, E.
    Reviriego, J.
    Thieu, V. T.
    Jiletcovici, A.
    [J]. DIABETIC MEDICINE, 2019, 36 : 130 - 130
  • [7] Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
    Heller, Simon
    Battelino, Tadej
    Bailey, Timothy S.
    Pieber, Thomas R.
    Hoevelmann, Ulrike
    Plum-Moerschel, Leona
    Melgaard, Anita E.
    Aronson, Ronnie
    DiMeglio, Linda A.
    Johansen, Thue
    Danne, Thomas
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (05): : 1351 - 1360
  • [8] Indirect treatment comparison of ready-to-use glucagon rescue treatments for severe hypoglycaemia: nasal glucagon versus liquid stable glucagon
    Yan, Y.
    Child, C. J.
    Syring, K.
    Wang, Q.
    Threlkeld, R.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 291 - 291
  • [9] Determinants of severe hypoglycaemia in a French population of adults with type 1 diabetes in 2015
    Julla, J. -B.
    de Boissieu, P.
    Trecan, T. Vidal
    Bouche, C.
    Kevorkian, J. -P.
    Laloi, M.
    Feron, F.
    Salle, L.
    Juddoo, V.
    Sarron, T.
    Leblanc, H.
    Gautier, J. -F.
    Riveline, J. -P.
    [J]. DIABETOLOGIA, 2016, 59 : S395 - S395
  • [10] Nasal glucagon for the treatment of moderate to severe hypoglycaemia episodes in children and adolescents with type 1 diabetes in home or school settings
    Guzman, C. B.
    Deeb, L.
    Dulude, H.
    Zhang, M.
    Zhang, S.
    Reiner, B. J.
    Piche, C. A.
    [J]. DIABETOLOGIA, 2017, 60 : S337 - S338